Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Diabetic Neurological Disorder Therapeutic Drug market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Diabetic Neurological Disorder Therapeutic Drug market segmented into
Capsule
Pills
Others
Based on the end-use, the global Diabetic Neurological Disorder Therapeutic Drug market classified into
Symmetrical Neuropathy
Focal and Multifocal Neuropathy
Based on geography, the global Diabetic Neurological Disorder Therapeutic Drug market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
AstraZeneca
Johnson & Johnson
Takeda
Mitsubishi Chemical
Avanir Pharmaceuticals
Dong-A Pharmaceutical Co., Ltd.
Immune Pharmaceuticals
MediciNova
Sangamo BioSciences
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DIABETIC NEUROLOGICAL DISORDER THERAPEUTIC DRUG INDUSTRY
2.1 Summary about Diabetic Neurological Disorder Therapeutic Drug Industry
2.2 Diabetic Neurological Disorder Therapeutic Drug Market Trends
2.2.1 Diabetic Neurological Disorder Therapeutic Drug Production & Consumption Trends
2.2.2 Diabetic Neurological Disorder Therapeutic Drug Demand Structure Trends
2.3 Diabetic Neurological Disorder Therapeutic Drug Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Capsule
4.2.2 Pills
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Symmetrical Neuropathy
4.3.2 Focal and Multifocal Neuropathy
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Capsule
5.2.2 Pills
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Symmetrical Neuropathy
5.3.2 Focal and Multifocal Neuropathy
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Capsule
6.2.2 Pills
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Symmetrical Neuropathy
6.3.2 Focal and Multifocal Neuropathy
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Capsule
7.2.2 Pills
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Symmetrical Neuropathy
7.3.2 Focal and Multifocal Neuropathy
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Capsule
8.2.2 Pills
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Symmetrical Neuropathy
8.3.2 Focal and Multifocal Neuropathy
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Capsule
9.2.2 Pills
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Symmetrical Neuropathy
9.3.2 Focal and Multifocal Neuropathy
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AstraZeneca
10.1.2 Johnson & Johnson
10.1.3 Takeda
10.1.4 Mitsubishi Chemical
10.1.5 Avanir Pharmaceuticals
10.1.6 Dong-A Pharmaceutical Co., Ltd.
10.1.7 Immune Pharmaceuticals
10.1.8 MediciNova
10.1.9 Sangamo BioSciences
10.2 Diabetic Neurological Disorder Therapeutic Drug Sales Date of Major Players (2017-2020e)
10.2.1 AstraZeneca
10.2.2 Johnson & Johnson
10.2.3 Takeda
10.2.4 Mitsubishi Chemical
10.2.5 Avanir Pharmaceuticals
10.2.6 Dong-A Pharmaceutical Co., Ltd.
10.2.7 Immune Pharmaceuticals
10.2.8 MediciNova
10.2.9 Sangamo BioSciences
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
1.Table Diabetic Neurological Disorder Therapeutic Drug Product Type Overview
2.Table Diabetic Neurological Disorder Therapeutic Drug Product Type Market Share List
3.Table Diabetic Neurological Disorder Therapeutic Drug Product Type of Major Players
4.Table Brief Introduction of AstraZeneca
5.Table Brief Introduction of Johnson & Johnson
6.Table Brief Introduction of Takeda
7.Table Brief Introduction of Mitsubishi Chemical
8.Table Brief Introduction of Avanir Pharmaceuticals
9.Table Brief Introduction of Dong-A Pharmaceutical Co., Ltd.
10.Table Brief Introduction of Immune Pharmaceuticals
11.Table Brief Introduction of MediciNova
12.Table Brief Introduction of Sangamo BioSciences
13.Table Products & Services of AstraZeneca
14.Table Products & Services of Johnson & Johnson
15.Table Products & Services of Takeda
16.Table Products & Services of Mitsubishi Chemical
17.Table Products & Services of Avanir Pharmaceuticals
18.Table Products & Services of Dong-A Pharmaceutical Co., Ltd.
19.Table Products & Services of Immune Pharmaceuticals
20.Table Products & Services of MediciNova
21.Table Products & Services of Sangamo BioSciences
22.Table Market Distribution of Major Players
23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
25.Table Global Diabetic Neurological Disorder Therapeutic Drug Market Forecast (Million USD) by Region 2021f-2026f
26.Table Global Diabetic Neurological Disorder Therapeutic Drug Market Forecast (Million USD) Share by Region 2021f-2026f
27.Table Global Diabetic Neurological Disorder Therapeutic Drug Market Forecast (Million USD) by Demand 2021f-2026f
28.Table Global Diabetic Neurological Disorder Therapeutic Drug Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Diabetic Neurological Disorder Therapeutic Drug Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Diabetic Neurological Disorder Therapeutic Drug Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Diabetic Neurological Disorder Therapeutic Drug Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Diabetic Neurological Disorder Therapeutic Drug Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Diabetic Neurological Disorder Therapeutic Drug Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Diabetic Neurological Disorder Therapeutic Drug Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Diabetic Neurological Disorder Therapeutic Drug Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Pills Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Symmetrical Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Focal and Multifocal Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Pills Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Symmetrical Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Focal and Multifocal Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Pills Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Symmetrical Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Focal and Multifocal Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Pills Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Symmetrical Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Focal and Multifocal Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Pills Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Symmetrical Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Focal and Multifocal Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Pills Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Symmetrical Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Focal and Multifocal Neuropathy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Diabetic Neurological Disorder Therapeutic Drug Sales Revenue (Million USD) of AstraZeneca 2017-2020e
66.Figure Diabetic Neurological Disorder Therapeutic Drug Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
67.Figure Diabetic Neurological Disorder Therapeutic Drug Sales Revenue (Million USD) of Takeda 2017-2020e
68.Figure Diabetic Neurological Disorder Therapeutic Drug Sales Revenue (Million USD) of Mitsubishi Chemical 2017-2020e
69.Figure Diabetic Neurological Disorder Therapeutic Drug Sales Revenue (Million USD) of Avanir Pharmaceuticals 2017-2020e
70.Figure Diabetic Neurological Disorder Therapeutic Drug Sales Revenue (Million USD) of Dong-A Pharmaceutical Co., Ltd. 2017-2020e
71.Figure Diabetic Neurological Disorder Therapeutic Drug Sales Revenue (Million USD) of Immune Pharmaceuticals 2017-2020e
72.Figure Diabetic Neurological Disorder Therapeutic Drug Sales Revenue (Million USD) of MediciNova 2017-2020e
73.Figure Diabet
